Skip to main content
Anne Angiolillo, MD, Pediatric Hematology & Oncology, Washington, DC

AnneLAngiolilloMD

Pediatric Hematology & Oncology Washington, DC

Professor, Pediatrics, G Washington University School of Medicine & Hlth Sci

Are you Dr. Angiolillo?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 59 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    111 Michigan Ave Nw
    Washington, DC 20010
    Phone+1 202-884-2140

Summary

  • Dr. Anne Angiolillo, MD is a pediatric hematologist/oncologist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia, Maryland, and Virginia. She is a Professor at G Washington University School of Medicine & Hlth Sci.

Education & Training

  • Children's National Hospital/George Washington University
    Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1992 - 1995
  • Children's National Hospital
    Children's National HospitalResidency, Pediatrics, 1989 - 1992
  • New York Medical College
    New York Medical CollegeClass of 1989

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1991 - 2022
  • MD State Medical License
    MD State Medical License 1995 - 2022
  • VA State Medical License
    VA State Medical License 1995 - 2022
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2012-2014
  • America's Top Doctors for Cancer Castle Connolly, 2011-2013
  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-acute Lymphoblastic Leukemia: Results from the Randomized Children’s Oncology Group Study AALL1731December 2024